These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 7905013)
1. A new dosing regimen for esmolol to treat supraventricular tachyarrhythmia in Chinese patients. Ko WJ; Chu SH J Am Coll Cardiol; 1994 Feb; 23(2):302-6. PubMed ID: 7905013 [TBL] [Abstract][Full Text] [Related]
2. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias. Gray RJ; Bateman TM; Czer LS; Conklin CM; Matloff JM J Am Coll Cardiol; 1985 Jun; 5(6):1451-6. PubMed ID: 2860148 [TBL] [Abstract][Full Text] [Related]
4. Intravenous esmolol for the treatment of supraventricular tachyarrhythmia: results of a multicenter, baseline-controlled safety and efficacy study in 160 patients. The Esmolol Research Group. Am Heart J; 1986 Sep; 112(3):498-505. PubMed ID: 2875641 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of esmolol (ASL-8052: an ultrashort-acting beta-adrenergic blocking agent) for control of ventricular rate in supraventricular tachycardias. Byrd RC; Sung RJ; Marks J; Parmley WW J Am Coll Cardiol; 1984 Feb; 3(2 Pt 1):394-9. PubMed ID: 6141193 [TBL] [Abstract][Full Text] [Related]
6. Interactions of esmolol and adenosine in atrioventricular nodal-dependent supraventricular tachycardia: implication for the cellular mechanisms of adenosine. Chang KC; Lin YC; Chen JY; Chou HT; Hung JS Cardiology; 2002; 97(3):138-46. PubMed ID: 12077566 [TBL] [Abstract][Full Text] [Related]
7. Esmolol in the treatment of supraventricular tachyarrhythmias. Das G; Ferris J Can J Cardiol; 1988 May; 4(4):177-80. PubMed ID: 2899451 [TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and tolerance of esmolol to propranolol for control of supraventricular tachyarrhythmia. Morganroth J; Horowitz LN; Anderson J; Turlapaty P Am J Cardiol; 1985 Oct; 56(11):33F-39F. PubMed ID: 2864847 [TBL] [Abstract][Full Text] [Related]
9. Esmolol: safety and efficacy in postoperative cardiothoracic patients with supraventricular tachyarrhythmias. Schwartz M; Michelson EL; Sawin HS; MacVaugh H Chest; 1988 Apr; 93(4):705-11. PubMed ID: 2894920 [TBL] [Abstract][Full Text] [Related]
10. Comparison of esmolol and nitroprusside for acute post-cardiac surgical hypertension. Gray RJ; Bateman TM; Czer LS; Conklin C; Matloff JM Am J Cardiol; 1987 Apr; 59(8):887-91. PubMed ID: 2881481 [TBL] [Abstract][Full Text] [Related]
11. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol. Barbier GH; Shettigar UR; Appunn DO Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691 [TBL] [Abstract][Full Text] [Related]
12. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol. Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and antiarrhythmic effects of esmolol in children. Trippel DL; Wiest DB; Gillette PC J Pediatr; 1991 Jul; 119(1 Pt 1):142-7. PubMed ID: 1676729 [TBL] [Abstract][Full Text] [Related]
15. Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia. Sung RJ; Blanski L; Kirshenbaum J; MacCosbe P; Turlapaty P; Laddu AR J Clin Pharmacol; 1986 Mar; 26(S1):A15-A26. PubMed ID: 2870082 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of esmolol in the treatment and transfer of patients with supraventricular tachyarrhythmias to alternate oral antiarrhythmic agents. Das G; Tschida V; Gray R; Dhurandhar R; Lester R; McGrew F; Askenazi J; Kaplan K; Emanuele M; Turlapaty P J Clin Pharmacol; 1988 Aug; 28(8):746-50. PubMed ID: 2905710 [TBL] [Abstract][Full Text] [Related]
17. Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study. Xiao J; He P; Zou Q; Zhao Y; Xue Z; Deng X; Li S; Guo Q; Tao G; Yang T; Lang Z; He J; Wang X J Clin Anesth; 2015 Mar; 27(2):120-8. PubMed ID: 25434501 [TBL] [Abstract][Full Text] [Related]
19. Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique. Reves JG; Croughwell ND; Hawkins E; Smith LR; Jacobs JR; Rankin S; Lowe J; VanTrigt P J Thorac Cardiovasc Surg; 1990 Aug; 100(2):221-7. PubMed ID: 1974664 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias. The Esmolol vs Placebo Multicenter Study Group. Anderson S; Blanski L; Byrd RC; Das G; Engler R; Laddu A; Lee R; Rajfer S; Schroeder J; Steck JD Am Heart J; 1986 Jan; 111(1):42-8. PubMed ID: 2868645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]